Pricing Log in Create free account

Precision BioSciences, Inc. (DTIL) vs Innate Pharma S.A. Sponsored ADR (IPHA)

Precision BioSciences, Inc. and Innate Pharma S.A. Sponsored ADR are both Biotechnology companies. Precision BioSciences, Inc. and Innate Pharma S.A. Sponsored ADR are of similar size ($170.3M and $165.3M). Innate Pharma S.A. Sponsored ADR grew revenue faster over the last twelve months: −4.17% against −11.9%. Precision BioSciences, Inc. has the higher net margin (0.00% vs −99.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Innate Pharma S.A. Sponsored ADR leads on 8 and Precision BioSciences, Inc. on 5.

Valuation

Metric DTIL IPHA Biotechnology median
P/E n/m n/m 8.50
P/S 3.31 n/m 9.71
P/B 3.29 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.87 0.12 9.21
Earnings yield (48.35%) (81.58%) (33.15%)
Free cash flow yield (35.07%) 0.00% (25.50%)

Profitability

Metric DTIL IPHA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (99.70%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (132.91%) 0.00% (56.36%)
Return on assets (44.91%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DTIL IPHA Biotechnology median
Revenue growth (TTM) (11.87%) (4.17%) 6.02%
EPS growth (last fiscal year) (442.31%) 6.06% 30.26%
Revenue growth, 5-year CAGR 7.13% (33.86%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL IPHA Biotechnology median
Debt to equity 0.50 (0.50) 0.00
Current ratio 12.82 0.60 4.72
Net debt to EBITDA 1.86 0.22 0.96

Dividend

Metric DTIL IPHA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DTIL IPHA Biotechnology median
Market cap 170.30m 165.32m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack